When approximately one million people gathered in New York’s Times Square on December 31, 2018, most of them didn’t know they were standing in front of cannabis history being made as the ball dropped into 2019. But that night, a handful of hemp- and marijuana-related companies became the first of their kind to advertise in some of the most coveted real estate in the world. One of those companies was Elixinol, a hemp and CBD company based in Broomfield.
Don’t let the suburban headquarters fool you: Elixinol has been pushing the tired boundaries of cannabis advertising for some time now, building itself into an internationally known cannabinoid company. To learn more about the firm’s bid for Times Square and its plans for the future, we talked with founder and former physical therapist Gabriel Ettenson.